Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > India's Bayer CropScience posts higher quarterly profit on strong herbicide, corn seed demand
    Finance

    India's Bayer CropScience posts higher quarterly profit on strong herbicide, corn seed demand

    Published by Global Banking & Finance Review®

    Posted on August 6, 2025

    2 min read

    Last updated: January 22, 2026

    India's Bayer CropScience posts higher quarterly profit on strong herbicide, corn seed demand - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:agricultural sectorsfinancial managementcorporate profitsInvestment opportunitiesmarket capitalisation

    Quick Summary

    Bayer CropScience's Q1 profit rose 9.6%, driven by herbicide and corn seed sales, with revenue up 17.4% amid favorable monsoon forecasts.

    Table of Contents

    • Bayer CropScience Financial Performance
    • Quarterly Profit and Revenue Growth
    • Market Context and Future Outlook
    • Peer Comparison
    • Valuation and Analyst Sentiment

    Bayer CropScience Sees 9.6% Profit Increase Driven by Herbicide and Seed Sales

    Bayer CropScience Financial Performance

    (Reuters) -Agricultural chemicals maker Bayer CropScience posted a 9.6% rise in first-quarter profit on Wednesday, backed by strong demand for its herbicide 'Roundup' and corn seeds.

    Quarterly Profit and Revenue Growth

    The Indian unit of German drugs and pesticides maker Bayer AG posted a profit of 2.79 million rupees ($31,834.8) for the three months ended June 30, compared with 2.54 billion rupees a year earlier.

    Market Context and Future Outlook

    Revenue from operations grew 17.4% to 19.15 billion rupees.

    Peer Comparison

    For further results highlights, click (Full Story)

    Valuation and Analyst Sentiment

    KEY CONTEXT

    India’s agrochemical companies, both domestic-focused and export-oriented, are expected to report healthy volume growth on the forecast of a normal monsoon, analysts said.

    The company said its growth in earnings is primarily driven by higher sales volume of corn seeds and its herbicide 'Roundup', supported by the early onset of monsoon.

    PEER COMPARISON

    Valuation (next 12 Estimates (next 12 Analysts' sentiment

    months) months)

    RIC PE EV/EBITDA Revenue Profit Mean No. of Stock to Div

    growth (%) growth (%) rating* analyst price yield

    s target** (%)

    Bayer Cropscience 35.25 26.23 10.01 25.04 Hold 8 1.07 2.00

    Coromandel 30.29 19.75 13.01 29.42 Buy 10 0.97 0.47

    International

    UPL 18.64 7.94 7.49 71.07 Buy 18 0.98 0.84

    Rallis India 32.93 17.40 13.47 47.42 Sell 13 1.32 0.66

    * Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell

    ** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT

    APRIL-JUNE STOCK PERFORMANCE

    -- All data from LSEG

    -- $1 = 87.6400 rupees

    (Reporting by Yagnoseni Das in Bengaluru; Editing by Ronojoy Mazumdar and Harikrishnan Nair)

    Key Takeaways

    • •Bayer CropScience's profit increased by 9.6% in Q1.
    • •Strong demand for herbicide 'Roundup' and corn seeds boosted sales.
    • •Revenue from operations grew by 17.4%.
    • •India's agrochemical sector benefits from a normal monsoon forecast.
    • •Bayer AG's Indian unit sees positive market sentiment.

    Frequently Asked Questions about India's Bayer CropScience posts higher quarterly profit on strong herbicide, corn seed demand

    1What is profit?

    Profit is the financial gain obtained when the revenue generated from business activities exceeds the costs associated with those activities.

    2What are herbicides?

    Herbicides are chemical substances used to control or kill unwanted plants, commonly used in agriculture to enhance crop yields.

    3What is revenue growth?

    Revenue growth refers to the increase in a company's sales over a specific period, indicating improved business performance.

    4What is market capitalisation?

    Market capitalisation is the total market value of a company's outstanding shares, calculated by multiplying the share price by the total number of shares.

    5What is corporate profit?

    Corporate profit is the net income of a corporation after all expenses, taxes, and costs have been deducted from total revenue.

    More from Finance

    Explore more articles in the Finance category

    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Image for Investors look beyond US hedge funds for the first time since 2023, Barclays says
    Investors look beyond US hedge funds for the first time since 2023, Barclays says
    Image for Analysis-ECB's safety net is part of EU plan to court new allies
    Analysis-ECB's safety net is part of EU plan to court new allies
    Image for Acciona, ACS and others win $4 billion railway contract in Australia
    Acciona, ACS and others win $4 billion railway contract in Australia
    Image for Renault to appeal German ruling in patent dispute with Broadcom
    Renault to appeal German ruling in patent dispute with Broadcom
    Image for EU proposes service ban for Russian oil exports in new sanctions package
    EU proposes service ban for Russian oil exports in new sanctions package
    Image for "A blessing": Hopeful Argentine farmers greet rain with relief, but still worried about risks to harvest
    "A blessing": Hopeful Argentine farmers greet rain with relief, but still worried about risks to harvest
    Image for Chery to start production in Spain this year after delays
    Chery to start production in Spain this year after delays
    View All Finance Posts
    Previous Finance PostSabadell shareholders approve TSB sale, $2.9 billion special dividend
    Next Finance PostEuropean healthcare stocks hit fresh lows after Trump's tariff threat